Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -111.00% is 44% above its 5-year average of -199.26%, near the high end of its 5-year range (-473.63%–-29.78%).
41.46% below its 12-month average of -78.47%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -53.45%.
OPERATING MARGIN
-111.00%
OPERATING MARGIN AVG TTM
-78.47%
OPERATING MARGIN AVG 3Y
-137.49%
OPERATING MARGIN AVG 5Y
-199.26%
OPERATING MARGIN AVG 10Y
-181.31%
OPERATING MARGIN AVG 15Y
-128.56%
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-41.46%
CURRENT VS 3Y AVG
+19.27%
CURRENT VS 5Y AVG
+44.29%
CURRENT VS 10Y AVG
+38.78%
CURRENT VS 15Y AVG
+13.66%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 556 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Fortress Biotech, Inc.
Market Cap
$68.43M
Operating Margin
-111.00%
TTM Avg
-78.47%
3Y Avg
-137.49%
5Y Avg
-199.26%
Market Cap
$69.33M
Operating Margin
-1.72%
TTM Avg
3.29%
3Y Avg
-3.87%
5Y Avg
-2.22%
Market Cap
$68.12M
Operating Margin
-7.19%
TTM Avg
-4.82%
3Y Avg
-64.73%
5Y Avg
-128.10%
Market Cap
$70.09M
Operating Margin
-35141.00%
TTM Avg
-19895.75%
3Y Avg
-11796.10%
5Y Avg
-8345.47%
Market Cap
$65.81M
Operating Margin
-336.81%
TTM Avg
-194.53%
3Y Avg
-97.26%
5Y Avg
-64.84%
Market Cap
$70.86M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$64.06M
Operating Margin
-69.62%
TTM Avg
-71.11%
3Y Avg
-78.39%
5Y Avg
-54.75%
Market Cap
$62.78M
Operating Margin
2.49%
TTM Avg
-12.82%
3Y Avg
-6.08%
5Y Avg
-11.76%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | $68.43M | -111.00% | -78.47% | -137.49% | -199.26% |
| Champions Oncology, Inc. (CSBR)vs › | $69.33M | -1.72% | 3.29% | -3.87% | -2.22% |
| Heron Therapeutics, Inc. (HRTX)vs › | $68.12M | -7.19% | -4.82% | -64.73% | -128.10% |
| iBio, Inc. (IBIO)vs › | $70.09M | -35141.00% | -19895.75% | -11796.10% | -8345.47% |
| Gossamer Bio, Inc. (GOSS)vs › | $65.81M | -336.81% | -194.53% | -97.26% | -64.84% |
| Cingulate Inc. (CING)vs › | $65.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| PDS Biotechnology Corporation (PDSB)vs › | $70.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| Alps Group Inc (ALPS)vs › | $64.06M | -69.62% | -71.11% | -78.39% | -54.75% |
| InterCure Ltd. (INCR)vs › | $62.78M | 2.49% | -12.82% | -6.08% | -11.76% |
| Kalaris Therapeutics Inc (KLRS)vs › | $63.95M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
62.5%
Operating Margin
-111.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -53.45% |
| 2026-03-31 | -48.25% |
| 2025-12-31 | -29.78% |
| 2025-09-30 | -38.63% |
| 2025-06-30 | -222.22% |
| 2025-03-31 | -169.85% |
| 2024-12-31 | -180.85% |
| 2024-09-30 | -151.04% |
| 2024-06-30 | -186.55% |
| 2024-03-31 | -280.63% |
| 2023-12-31 | -98.34% |
| 2023-09-30 | -39.59% |
| 2023-06-30 | -288.19% |
| 2023-03-31 | -473.63% |
| 2022-12-31 | -333.05% |
| 2022-09-30 | -306.96% |
| 2022-06-30 | -269.65% |
| 2022-03-31 | -197.58% |
| 2021-12-31 | -339.25% |
| 2021-09-30 | -236.77% |
| 2021-06-30 | -240.19% |
| 2021-03-31 | -259.06% |
| 2020-12-31 | -176.76% |
| 2020-09-30 | -243.20% |
| 2020-06-30 | -268.54% |
| 2020-03-31 | -166.65% |
| 2019-12-31 | -272.96% |
| 2019-09-30 | -230.66% |
| 2019-06-30 | -273.41% |
| 2019-03-31 | -503.44% |
| 2018-12-31 | 22.44% |
| 2018-09-30 | -44.28% |
| 2018-06-30 | -39.79% |
| 2018-03-31 | -61.65% |
| 2017-12-31 | -61.42% |
| 2017-09-30 | -69.54% |
| 2017-06-30 | -45.75% |
| 2017-03-31 | -39.34% |
| 2016-12-31 | -152.49% |
| 2016-09-30 | -1666.26% |
| 2016-06-30 | -678.74% |
| 2016-03-31 | -2286.52% |
| 2015-12-31 | -3735.50% |
| 2015-09-30 | -72288.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | -2414.20% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
